MARGONI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.359
EU - Europa 245
AS - Asia 127
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.734
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.359
CN - Cina 112
IT - Italia 112
SE - Svezia 33
FR - Francia 25
FI - Finlandia 22
GB - Regno Unito 20
DE - Germania 11
IE - Irlanda 5
UA - Ucraina 5
IN - India 4
JP - Giappone 4
CH - Svizzera 3
KR - Corea 3
NL - Olanda 3
ES - Italia 2
MK - Macedonia 2
TR - Turchia 2
AZ - Azerbaigian 1
BE - Belgio 1
BR - Brasile 1
EC - Ecuador 1
EU - Europa 1
IL - Israele 1
PL - Polonia 1
Totale 1.734
Salva come PNG Salva come JPEG
Città #
Fairfield 262
Chandler 168
Ashburn 136
Woodbridge 135
Cambridge 97
Houston 88
Seattle 81
Wilmington 53
Ann Arbor 42
Beijing 38
Medford 27
Princeton 27
Roxbury 24
Milan 20
Helsinki 19
San Diego 18
Des Moines 17
Guangzhou 13
Padova 12
Paris 12
Shanghai 11
Nanjing 8
Cagliari 6
Casatenovo 5
Castelfranco Veneto 5
Dublin 5
Kharkiv 5
Los Angeles 5
New York 5
Norwalk 5
Rome 5
London 4
Basel 3
Genoa 3
Gyeonggi-do 3
Jinan 3
Ogden 3
Redwood City 3
Southwark 3
Albignasego 2
Altinordu 2
Amsterdam 2
Atri 2
Boardman 2
Boston 2
Changsha 2
Columbus 2
Cosenza 2
Haikou 2
Harada 2
Hebei 2
Islington 2
Jerez de la Frontera 2
Jīnd 2
Lappeenranta 2
Lipari 2
Monza 2
Noale 2
Prescot 2
Sassari 2
Skopje 2
Trento 2
Valera Fratta 2
Vicenza 2
Atlanta 1
Baku 1
Birmingham 1
Brussels 1
Cafasse 1
Caldogno 1
Chiswick 1
Dongguan 1
Frosinone 1
Fumane 1
Glasgow 1
Hamburg 1
Hangzhou 1
Hounslow 1
Kilburn 1
Kronberg 1
Kunming 1
Larkhall 1
Limana 1
Morgantown 1
Nuremberg 1
Portland 1
Quito 1
Shenyang 1
Taiyuan 1
Tel Aviv 1
Tokyo 1
Torri di Quartesolo 1
Turin 1
Verona 1
Vigonza 1
Warsaw 1
Washington 1
Totale 1.462
Salva come PNG Salva come JPEG
Nome #
Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis 108
Ophthalmoplegic migraine: Could electroencephalogram still be a useful tool to better understand the pathogenetic mechanism? 99
A new Italian family with HTRA1 mutation associated with autosomal-dominant variant of CARASIL: Are we pointing towards a disease spectrum? 92
Monitoring Progressive Multiple Sclerosis with Novel Imaging Techniques 86
No evidence of disease activity including cognition (NEDA-3 plus) in naïve pediatric multiple sclerosis patients treated with natalizumab 83
Cerebellar gray matter lesions are common in pediatric multiple sclerosis at clinical onset. 79
Isolated choroid plexus involvement in a case of granulomatosis with polyangiitis negative for antineutrophil cytoplasmic antibodies (ANCA) 77
Slowly Progressive Optic Perineuritis as the First Clinical Manifestation of Sarcoidosis 75
null 71
Early red nucleus atrophy in relapse-onset multiple sclerosis 67
Effects of disease modifying therapies on brain and grey matter atrophy in relapsing remitting multiple sclerosis 66
Axonal water fraction as marker of white matter injury in primary-progressive multiple sclerosis: a longitudinal study 63
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study 62
Idiopathic hypertrophic cranial pachymeningitis as a rare cause of status epilepticus 61
Hematoma of Meckel's cave: a rare possible symptomatic trigeminal neuralgia 59
Ophthalmoplegic migraine: could electroencephalogram still be a useful tool to better understand the pathogenetic mechanism? 55
Quantificazione del danno microstrutturale nella sclerosi multipla attraverso il rapporto delle sequenze pesate in T1 e T2: uno studio multicentrico 55
A novel mutation in ABCD1 unveils different clinical phenotypes in a family with adrenoleukodystrophy 53
Alemtuzumab following natalizumab in highly active paediatric-onset multiple sclerosis 50
Very late-onset recurrent myelitis in a patient diagnosed with antiphospholipid syndrome: A puzzle of autoimmunity 49
Ketogenic diet in migraine treatment: a brief but ancient history 48
Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic 44
Neurite orientation dispersion and density imaging discloses early changes in the normal-appearing white matter in paediatric multiple sclerosis 41
Quantification of normal-appearing white matter damage in early relapse-onset multiple sclerosis through neurite orientation dispersion and density imaging 36
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives 33
Retinal Hyperreflecting Foci Associate With Cortical Pathology in Multiple Sclerosis 24
Cerebellar pathology and disability worsening in relapsing‐remitting multiple sclerosis: a retrospective analysis from the CombiRx trial 20
Selective Cerebellar Atrophy Associates with Depression and Fatigue in the Early Phases of Relapse-Onset Multiple Sclerosis 18
null 18
Alemtuzumab-induced autoimmune thyroid events in patients with relapsing-remitting multiple sclerosis: A real-life and monocentric experience at a tertiary-level centre 16
Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities 14
Alemtuzumab-induced autoimmune thyroid events in patients with relapsing-remitting multiple sclerosis: A real-life and monocentric experience at a tertiary-level centre 13
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD 9
Influence of cardiorespiratory fitness and MRI measures of neuroinflammation on hippocampal volume in multiple sclerosis 9
Trans-synaptic degeneration in the optic pathway: Exploring the role of lateral geniculate nucleus in early stages of relapsing-remitting multiple sclerosis 8
Does Ocrelizumab Limit Multiple Sclerosis Progression? Current Evidence from Clinical, MRI, and Fluid Biomarkers 5
Pediatric multiple sclerosis: developments in timely diagnosis and prognostication 4
Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study 3
Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis 3
Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis 2
Emerging Perspectives on MRI Application in Multiple Sclerosis: Moving from Pathophysiology to Clinical Practice 2
In vivo quantification of brain soma and neurite density abnormalities in multiple sclerosis 2
A Fully Automatic Method to Segment Choroid Plexuses in Multiple Sclerosis Using Conventional MRI Sequences 2
Paramagnetic rim and core sign lesions in paediatric multiple sclerosis patients 2
Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study 1
Choroid plexus enlargement in paediatric multiple sclerosis: clinical relevance and effect of sex 1
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 1
Totale 1.789
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.599
article - articoli 8.488
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.087
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201962 0 0 0 0 0 0 0 0 0 0 31 31
2019/2020345 19 13 0 14 27 15 36 33 42 89 26 31
2020/2021358 13 50 12 28 45 16 8 45 45 43 43 10
2021/2022351 5 14 29 17 36 37 24 31 47 8 26 77
2022/2023340 54 30 14 35 48 48 2 27 45 13 17 7
2023/2024285 12 28 23 41 34 28 40 21 26 32 0 0
Totale 1.789